opens in a new window
Quay News
Overcoming Obstacles in the Development of Live Biotherapeutic Products
Live Biotherapeutic Products (LBPs) are a promising area of research and development for treating a wide range of…
What is a CDMO? And why partner with one?
A CDMO is a company that provides services to the pharmaceutical and biotechnology industries. These organizations offer…
SGS Quay Pharma’s Facility Brings Formulation and Manufacturing Expertise to North America
The need for comprehensive, technically advanced, and integrated services from contract service providers is needed now more than ever.
Careers in the USA at SGS Quay Pharma
Find your next role at SGS Quay Pharma in the USA
Careers in the UK at SGS Quay Pharma
Find your next role at SGS Quay Pharma in the UK
SGS Quay Pharma Receives Queen’s Award for Industry
SGS Quay Pharma has received its Queen’s Award for Enterprise. The award was presented by…
SGS’s Quay Pharma Collaborates to Develop New Oral Medicine for Inflammatory Bowel Disease
SGS’s Quay Pharma has partnered with Intract Pharma, CPI and Pharmidex to successfully…
New Hampshire Pharmaceutical Development and Clinical Manufacturing Facility Nears Completion
We will soon open our Hudson, NH, pharmaceutical development and clinical manufacturing facility.
SGS Quay’s Microbiome Expertise Ideal For New IBD Drug Development Project
SGS Quay Pharma is partnering on a major project to develop and commercialise an inflammatory…
INSPECTED FACILITIES
